Ralf Westenfeld
Overview
Explore the profile of Ralf Westenfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
271
Citations
3402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thevathasan T, Wahl V, Boettel J, Kenny M, Paul J, Selzer S, et al.
Resusc Plus
. 2025 Feb;
22:100888.
PMID: 40008321
Background: Recent trials suggested that extracorporeal cardio-pulmonary resuscitation (ECPR) with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or "ECMELLA" (VA-ECMO plus Impella®) may improve short-term survival and neurological outcomes in selected patients...
2.
Spieker M, Sidabras J, Lagarden H, Christian L, Gunther N, Angendohr S, et al.
ESC Heart Fail
. 2025 Jan;
PMID: 39829434
Aims: Ischaemic mitral regurgitation (MR) is a dynamic condition influenced by global and regional left ventricular remodelling as well as mitral valvular deformation. Exercise testing plays a substantial role in...
3.
Borger J, Zweck E, Moos C, Horn P, Voss F, Schultheiss H, et al.
ESC Heart Fail
. 2024 Oct;
PMID: 39477690
Aims: Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy...
4.
Zweck E, Hassager C, Beske R, Jensen L, Eiskjaer H, Mangner N, et al.
Circulation
. 2024 Oct;
150(25):1990-2003.
PMID: 39462276
Background: In DanGer Shock (the Danish-German Cardiogenic Shock trial), use of a microaxial flow pump (mAFP) in patients with ST-segment-elevation myocardial infarction-related cardiogenic shock led to lower all-cause mortality but...
5.
Balata M, Radbruch L, Hesse M, Westenfeld R, Neukirchen M, Pfister R, et al.
Lancet Healthy Longev
. 2024 Oct;
5(10):100637.
PMID: 39366392
Background: Heart failure is a substantial global health concern that severely affects patients' quality of life. We aimed to compare the effects of early integration of palliative care (EIPC) and...
6.
Bouvain P, Ding Z, Kadir S, Kleimann P, Kluge N, Tiren Z, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(2):126-143.
PMID: 39196054
Neutrophils play a complex role during onset of tissue injury and subsequent resolution and healing. To assess neutrophil dynamics upon cardiovascular injury, here we develop a non-invasive, background-free approach for...
7.
Voss F, Nienhaus F, Pietrucha S, Ruckhaberle E, Fehm T, Melz T, et al.
Cardiooncology
. 2024 Jul;
10(1):43.
PMID: 39014463
Aims: Cancer therapy-related cardiac dysfunction (CTRCD) is a dreaded complication of anthracycline therapy. CTRCD most frequently appears in patients with cardiovascular risk factors (CVR) or known cardiovascular disease. However, limited...
8.
Voss F, Zweck E, Ipek R, Schultheiss H, Roden M, Kelm M, et al.
JACC Heart Fail
. 2024 May;
12(10):1778-1780.
PMID: 38795111
No abstract available.
9.
Moller J, Engstrom T, Jensen L, Eiskjaer H, Mangner N, Polzin A, et al.
N Engl J Med
. 2024 Apr;
390(15):1382-1393.
PMID: 38587239
Background: The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock remains unclear. Methods:...
10.
Brockmeyer M, Parco C, Vargas K, Westenfeld R, Jung C, Kelm M, et al.
J Nephrol
. 2024 Jan;
37(2):309-321.
PMID: 38236473
Background: Absolute treatment benefits-expressed as numbers needed to treat-of the glucose lowering and cardiovascular drugs, glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose transporter 2 (SGLT2) inhibitors on renal outcomes remain...